U.S. Poultry And Egg Exports Set Record Last Year

Feb 15, 2023

U.S. poultry and egg exports in 2022 set a record at $6.234 billion, up 12.4 percent over 2021, with broiler exports reaching an all-time high in both volume and value, according to new trade data released by the USDA Foreign Agricultural Service.

U.S. broiler exports to the Philippines, Congo (Brazzaville), Gambia, Mauritania, Benin, and Guinea in 2022 reached all-time highs in volume and value, while exports to China and Taiwan set records in value. Also, Angola, Georgia, Vietnam, Gabon, Singapore, Canada, Turkmenistan, Iraq, and Chile showed tremendous gains in broiler exports from the previous year. Broiler exports in 2022 were 3,792,380 metric tons, up 4.6 percent from 2021, while export value reached $5.218 billion, up 17.0 percent.

Turkey exports in 2022 were 184,837 metric tons, down 25.6 percent from 2021, while export value was $641.6 million, down 3.6 percent (Figure 2). The decrease in export volume is due largely to HPAI detections in important turkey-producing states such as Minnesota, Indiana, and North Carolina. More than 9.44 million commercial turkey meat birds were affected by the end of December 2022. And U.S. turkey production in 2022 was 2.351 million metric tons, down 6.1 percent from the previous year.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.